★ America V2AuditLine ALPHA

AuditLine › HHS OIG › Centers for Medicare and Medicaid Services

HHS OIG recommendation 22-E-BL-027.02

CMS should pursue additional strategies�such as educating providers and pharmacies�to increase access to and use of lower-cost hepatitis C drugs in…

Closed ImplementedThe publisher's status, as reported by HHS Office of Inspector General in the file read .

The recommendation, in the publisher's words

CMS should pursue additional strategies�such as educating providers and pharmacies�to increase access to and use of lower-cost hepatitis C drugs in Medicare Part D.
Responsible agency
Centers for Medicare and Medicaid Services
Issued
August 9, 2022
Report
Part D Plan Preference for Higher-Cost Hepatitis C Drugs Led to Higher Medicare and Beneficiary Spending (OEI-BL-21-00200) · find it at HHS OIG
Kind of report
Evaluation
Agency response
Concur (as recorded by the publisher)
Closed
December 16, 2025 (publisher's date)
Publisher topics
Financial Stewardship, Prescription Drug

“Open” and “closed” are the publisher's words. AuditLine repeats them with the date it read them. It does not check whether a recommendation was carried out, and a closed recommendation is not proof that a problem was fixed.

Dated history

  1. Issued by HHS OIG. (publisher's date)
  2. Closed, with status “Closed Implemented”. (publisher's date)
  3. First recorded by AuditLine. (start of AuditLine's own history for this record)
  4. The publisher changed the recommendation's wording. (observed by AuditLine in the publisher's file)

Dates marked "publisher's date" come from the publisher's file. AuditLine's own observations begin November 10, 2026 and are added each time the publisher's file changes.

Other recommendations from this report

1 more, of which 1 is open in the publisher's file.

Source

Open this report in HHS OIG's tracker This publisher's records (CSV)

Official export: https://oig.hhs.gov/recommendations/export-recs/. File read , 4,677 rows, SHA-256 664fdfb3658ecb72…. HHS OIG's status, response, dates and potential-savings labels are the publisher's own claims.